Dr. David G. Rizik, MD
Cardiology (Cardiovascular Disease Physician)
7400 N Dobson Rd Ste 201
Scottsdale, AZ 85256
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Saint Louis University School of Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 877
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: Saint Louis University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
AZ license 21844
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Banner - University Medical Center Phoenix Phoenix, AZ
- Honorhealth Scottsdale Shea Medical Center Scottsdale, AZ
Medical groups
- Banner - University Physician Specialists LLC (348 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 877
- Services billed
- 1,608
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 498 | 478 |
| Established patient office or other outpatient visit, 30-39 minutes | 293 | 266 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 110 | 85 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 109 | 99 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 85 | 60 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 81 | 78 |
| New patient office or other outpatient visit, 45-59 minutes | 80 | 80 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 71 | 71 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 48 | 39 |
| Replacement of aortic valve through the skin and femoral artery | 44 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 50 payments worth $8,892 in total to this clinician.
| Siemens Medical Solutions USA, Inc. | $3,701 |
|---|---|
| Abbott Laboratories | $2,223 |
| Edwards Lifesciences Corporation | $1,419 |
| Teleflex LLC | $839 |
| Boston Scientific Corporation | $257 |
| Heartflow, Inc. | $208 |
| Medtronic, Inc. | $175 |
| Mimedx Group, Inc. | $46.30 |
| Compensation for services other than consulting (speaking, faculty) | $3,400 |
|---|---|
| Food and Beverage | $2,887 |
| Consulting Fee | $1,500 |
| Travel and Lodging | $1,105 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Siemens Medical Solutions USA, Inc. Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) ACUSON Origin Diagnostic Ultrasound System · US - Ultrasound Systems | $3,400 |
| Abbott Laboratories Mar 24, 2025 | Consulting Fee PRESSUREWIRE · Structural Heart | $1,500 |
| Edwards Lifesciences Corporation Sep 29, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $479 |
| Siemens Medical Solutions USA, Inc. Jul 30, 2025 | Travel and Lodging ACUSON SC2000 Diagnostic Ultrasound System · US - Ultrasound Systems · travel to Carlsbad, CA · in-kind | $301 |
| Edwards Lifesciences Corporation Oct 8, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $248 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $7.14 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5.46 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Siemens Medical Solutions USA, Inc. Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) ACUSON Origin Diagnostic Ultrasound System · US - Ultrasound Systems | $3,400 |
| Edwards Lifesciences Corporation Oct 8, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $248 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $7.14 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5.46 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5.15 |
| Edwards Lifesciences Corporation Sep 29, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $479 |
| Siemens Medical Solutions USA, Inc. Jul 30, 2025 | Travel and Lodging ACUSON SC2000 Diagnostic Ultrasound System · US - Ultrasound Systems · travel to Carlsbad, CA · in-kind | $301 |
| Abbott Laboratories Mar 24, 2025 | Consulting Fee PRESSUREWIRE · Structural Heart | $1,500 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 6 companies. The companies reported $108,453 in research payments for these studies, mostly to the institutions running them.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100 - ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Boston Scientific Corporation · Active, not recruiting · NCT03735667 - A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
Janssen Research & Development, LLC - JOURNEY (Trial JCM-002)
Edwards Lifesciences Corporation - EXPAND II
Medtronic, Inc. - NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Abbott Laboratories - NCT03904147--TRILUMINATE Pivotal Trial
Abbott Laboratories - NCT03309332--AMPLATZER PFO Occluder Post Approval Study
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.